The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells
The synergistic effects of CXCR4 and EGFR on promoting EGF-mediated metastasis in ovarian cancer cells
复制标题
DOI:
10.1016/j.colsurfb.2007.05.013
复制
发表时间:
2007-10-15
影响因子:
5.8
通讯作者:
Liu, Yiyao
中科院分区:
文献类型:
--
作者:
Guo, Zhigang;Cai, Shaoxi;Liu, Yiyao
CXC chemokine receptor 4 (CXCR4) is a cell surface receptor that has been reported to mediate the metastasis of many solid tumors including ovarian, breast, lung and prostate. The over-expression of the epidermal growth factor receptor (EGFR) is associated with the majority of ovarian cancer and has been implicated in the process of malignant transformation by promoting cell proliferation, survival, and motility. In this research, the result first showed that epidermis growth factor (EGF) enhanced the expression of CXCR4 and the migration of ovarian cancer cells, moreover, both stromal cell derived factor-1 alpha (SDF-1 alpha) and EGF-induced high matrix metallopepticlase 9 (MMP9) expressions. Molecular analysis indicated that augmented CXCR4 and MMP9 expression was regulated by phosphatidylinositol-3-kinase(PI3K)/Akt signal transduction pathway. These results suggested a possible important "cross-talk" between CXCR4 and EGFR intracellular pathways that might link signals of tumor deteriorated and provided a plausible explanation for the poor overall survival rate of patients whose co-expression of CXCR4 and EGFR was detected in their tissue sections. It enlightened that, compared to the respective inhibition of the EGFR or CXCR4 signaling, the simultaneous inhibition of them might be a more useful therapeutic strategy of cancer. (c) 2007 Elsevier B.V. All rights reserved.